CRA was retained by a Fortune 100 pharmaceutical company to assess the multi-year selection process associated with a recent acquisition. Working with the client CRA developed analyses to examine the impact decisions commonly associated with blending companies. The analyses incorporated different selection processes for areas of overlap, merger required spin-offs, as well as general workforce adjustments. CRA’s analyses provided a “real-time” review of the decisions as they were being made to address particular areas of risk.
Calif. bar touts reduction in racial disparity in atty discipline
The California Bar’s recent presentation of the report, reflecting data from 2018 through 2023 and approximately 122,000 attorneys, examined key factors that...